Study optimized fermentation for increased pulcherriminic acid production, suggesting strong agricultural applications.
Pulcherriminic acid (PA) is a typical microbial natural cyclic dipeptide and secondary metabolite. It serves as the biosynthetic precursor of pulcherrimin, an iron-chelating siderophore with promising potential for agricultural biocontrol. Low inherent biosynthesis severely limits its practical exploitation as a bioactive natural product. Here, we screened five Bacillus subtilis strains and selected 164T7P as the metabolic engineering chassis. Replacing the native promoter of the yvmC-cypX cluster with the xylose-inducible T7 promoter increased PA titer by 7.18-fold to 0.201 g/L. Knockout of abrB or spoIVB enhanced PA formation, whereas codY deletion suppressed its biosynthesis. Further optimization of carbon source, l-leucine supplementation and FeCl3 concentration raised the titer to 1.284 g/L at 0.6 g/L FeCl3. With glycerol as the primary feedstock supplemented with l-leucine and FeCl3, fed-batch fermentation in a 5-L bioreactor achieved a final PA titer of 3.91 g/L, the highest reported titer of this natural product to date. This study establishes an efficient biosynthetic platform for high-level production of PA and facilitates further development of this bioactive microbial natural product.
No takes yet. Share an insight, caveat, or question.
Zhuang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: